Alvotech
Ownership
Ownership Structure
Who owns Alvotech (ALVO)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 39.5% of the shares are freely tradable; institutional investors hold 5.2%.
Largest Shareholders
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard Total Intl Stock Index Inv | 0.47 | 1,671,323 | +0.0 | 08/31/2026 |
| Vanguard Emerging Mkts Stock Idx Inv | 0.45 | 1,610,386 | +0.0 | 08/31/2026 |
| T. Rowe Price International Discovery | 0.31 | 1,120,386 | +0.0 | 07/31/2026 |
| iShares Biotechnology ETF | 0.30 | 1,053,952 | +0.8 | 08/31/2026 |
| Stefnir Icelandic Growth | 0.25 | 887,661 | -0.1 | 08/31/2026 |
| L&G Frontier Markets Eq Z USD Acc | 0.18 | 655,193 | +8.2 | 07/31/2026 |
| Eaton Vance Glbl Macro Abs Ret Advtg I | 0.17 | 593,154 | +0.0 | 04/30/2026 |
| Vanguard FTSE All-Wld ex-US ETF | 0.08 | 275,828 | +7.2 | 08/31/2026 |
| iShares Genomics Immnlgy & Hlthcr ETF | 0.08 | 271,875 | +0.0 | 08/31/2026 |
| iShares Nasdaq US Biotech ETF USD Acc | 0.07 | 248,989 | +1.1 | 08/28/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.